C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 1/21 (2006.01) A61K 39/002 (2006.01) A61K 39/02 (2006.01) C12N 15/00 (2006.01) C12N 15/31 (2006.01) C12N 15/90 (2006.01)
Patent
CA 2085828
DIR 0499 Bl ABSTRACT According to the present invention a vaccine can be prepared containing a mutant Serpulina hyodysenteriae which is defective in its production of biologically active hemolysin. The mutation by which Serpulina hyodysen- teriae is made defective in its production of hemolytically active hemolysin is established by means of genetical engineering techniques. Such muta- tions comprise e.g. deletion of part or the entire gene coding for hemolysin and/or nucleotide sequences controling the production of hemolysin, or insertion of an extra nucleotide or polynucleotide into the gene encoding hemolysin and/or the nucleotide sequences controling the production of hemolysin, or a combination of said deletion and insertion. These vaccines are useful in the prevention of Serpulina infections in susceptible animals such as swine.
Muir Susie J.
Ter Huurne Agnes
Dimminaco Ag/sa/ltd.
Fetherstonhaugh & Co.
LandOfFree
Serpulina hyodysenteriae vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serpulina hyodysenteriae vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serpulina hyodysenteriae vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1932428